blogs  
 
yournews
   
 
Video Photos Finance Travel Weather Discussion TV Shows
| |
 
  Home ›
 
Health News

 

Omega 3 supplement targets bowel cancer risk: study
Posted: 18 March 2010 1452 hrs

 
 
Photos  of

   
 


PARIS : A purified form of omega 3, the so-called "good fat" found naturally in certain fish and nut oils, reduced dangerous polyps among people prone to bowel cancer, a study published on Thursday says.

Fifty patients were enrolled in the investigation, all with a genetic mutation that prompts the development of polyps - precancerous growths in the bowel that often develop into tumours requiring removal of large sections of intestine.

Twenty-eight were randomly assigned to a group that received a two-gramme daily dose of a new, highly purified form of omega 3, while the other 27 were given a dummy lookalike, or placebo.

After six months, the number of polyps had risen by almost 10 per cent among the placebo group but fell by 12 per cent for those taking the omega 3 capsules, amounting to a difference of more than 22 per cent.

In addition, polyp size increased by 17 per cent among the placebo takers, whereas it decreased by 12.5 per cent in the capsule group, a difference of just under 30 per cent.

These results are similar to a drug called celecoxib, marketed as Celebrex, which is used to inhibit polyps among genetically vulnerable patients.

However, celecoxib has been linked to cardiovascular side effects among older patients. In contrast, the omega 3 - full name eicosapentaeonic acid, or EPA - supplement was "very well tolerated," say the doctors.

The paper is published online by Gut, a journal of the British Medical Association (BMA).

- AFP/ra

 


Other health News
Cancer drug reverses Alzheimer's in mice: study
Smoking linked to mental decline in men, says study
Brains of addicts are inherently abnormal, says study
US study finds Alzheimer's spreads like infection
Pfizer recalls 1 million packets of US birth control pills
France urges Europe-wide controls after implant scare
New drug for rare cystic fibrosis gets US approval
Brain 'hears' from different location than earlier thought
Doctors should check blood pressure on both arms: study
Ultrasound zaps could be used as male contraceptives: study
Pneumonia bug evolves to evade vaccine
New lung cancer test predicts survival
Oral HPV infections more common in men: study
Can tablets give you a pain in the neck?
Alzheimer's: French scientists focus on key target

 

 
Affiliate Sites:
 
About Us  |  Contact Us  |  Advertise with Us  |  Terms & Conditions